Email Us Here
John A. McLane Named Executive of the Year in Pharmacovigilance & Operations Management
John A. McLane plans to develop innovative new drugs to treat rare diseases
John A. McLane Named Executive of the Year in Pharmacovigilance & Operations Management
John A. McLane plans to develop innovative new drugs to treat rare diseases